ENTA 8-K 2026-06-23

ENANTA PHARMACEUTICALS INC (ENTA) 8-K dated 2026-06-23 — accession 0001193125-26-279803. This URL is the filing, not the ENTA hub.

ENANTA PHARMACEUTICALS INC (ENTA) is a biotechnology company listed on US.

ENANTA PHARMACEUTICALS INC filed a 8-K on 2026-06-23. Accession 0001193125-26-279803.

Cached items: 8.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ENTA revenue for 2025-09-30 was $65.3M. Net income was -$81.9M. ENTA currently screens at market cap $328.0M.

Not investment advice. The ENTA SEC hub lists recent forms. The stock page is the research view.